Search

Cancer genetics and signalling pathways in ENT – a review and discussion of how this can be applied to rare tumours

Introduction Cancer cases continue to increase worldwide, and­­ head and neck cancer is a major global health issue, with an estimated global burden of over 630,000 new cases and over 350,000 deaths per year [1]. The term ‘head and neck...

Robotic head and neck surgery: current state of the art and future innovations

Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Lyric 24/7 hearing: could it help those with tinnitus?

About Lyric Hearing Since its launch in 2008, Lyric represents the first and only device of its kind establishing a new category of hearing solution: 24/7 extended wear. Lyric is placed several millimetres within the ear canal, near the tympanic...

Getting to grips with acoustic trauma

Our understanding of hearing loss caused by noise exposure to those in the armed forces is growing in interest and understanding. Research at a cellular level is essential to increase our understanding so that we can better diagnose, manage and...

Diabetes and hearing loss: a review

As hearing health professionals we often ask, especially in older patients, if they have diabetes; but what is the link? How is it manifested and should it change current practice? Alec Lapira reviews the changing evidence. Early attempts to establish...

Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities

How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Hearing rehabilitation after vestibular schwannoma surgery

Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...

Multi-channel cochlear implants: past, present and future

Forty years since the first multi-channel devices were implanted, who better than Ingeborg Hochmair, who has been a key figure throughout their evolution, to offer her thoughts on the past, present and future of multi-channel cochlear implants? Read on for...